Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs

Scandinavian Journal of Immunology

Volumn 52, Issue 4, 2000, Pages 401-410

  Rothermel, E ^a   Gotze, O ^a   Zahn, S ^a   Schlaf, G ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; G PROTEIN COUPLED RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY R63; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBODY PRODUCTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ACETYLGLUCOSAMINIDASE; AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CALCIUM; COMPLEMENT 5A; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, COMPLEMENT; SUPPORT, NON-U.S. GOV'T;

EID: 0033830250     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00795.x     Document Type: Article

References (31)

1. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a
2. Nucleotide and corrected amino acid sequence of the functional recombinant rat anaphylatoxin C5a
3. Complement: Biologically active products
4. Recombinant C5a enhances interleukin-1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages
5. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1
6. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin
7. C5a suppresses the production of IL-12 by human monocytes
8. The chemotactic receptor for human C5a anaphylatoxin
9. Structural diversity in the extracellular faces of peptidergic G-protein coupled receptors
10. Cloning and functional expression of the canine anaphylatoxin C5a receptor
11. Molecular cloning and expression of the functional rat C5a receptor
12. 2-terminal domain
13. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from predicted aminoterminal of the human C5a receptor
14. Cellular expression of the C5a anaphylatoxin receptor (C5aR): Demonstration of C5aR on non-myeloid cells of the liver and lung
15. Human T-cells express the C5a receptor and are chemoattractant to C5a
16. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen and bone marrow leukocytes
17. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes
18. Interleukin-3 dependent mediator release in basophils triggered by C5a
19. Characterization of a receptor for C5a anaphylatoxin on human eosinophils
20. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and hepatic stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver
21. 2+ release
22. The C5a receptor is expressed in renal proximal tubular but not in pulmonary or hepatic epithelial cells
23. Chemoattractant receptors for interleukin-8 and C5a: Expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid
24. 2+
25. Neutralizing monoclonal antibodies to human IL-8 receptor A map to the N-terminal region of the receptor
26. N-Formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation
27. 4-induced fibrotic rat livers
28. C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: Up-regulation by dexamethason, down-regulation by interferon gamma and lipopolysaccharide
29. Sinusoidal intercellular adhesion molecule-1 up-regulation precedes the accumulation of leukocyte function antigen-l-positive cells and tissue necrosis in a model of carbontetrachloride-induced acute rat liver injury
30. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease